Seroprevalence of Toxoplasmosis in HIV+/AIDS Patients in Iran

Toxoplasma gondii has arisen as an important opportunistic agent especially in the central nervous system and in advanced HIV disease can cause significant morbidity and mortality. This study was carried out to determine the seroprevalence of toxoplasmosis among HIV-positive patients in Iran. Blood...

Full description

Bibliographic Details
Main Authors: Minoo Mohraz, Farhad Mehrkhani, Sara Jam, Seyed Ahmad SeyedAlinaghi, Duman Sabzvari, Fatemeh Fattahi, Hossain Jabbari, Mahboubeh Hajiabdolbaghi
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2011-04-01
Series:Acta Medica Iranica
Subjects:
Online Access:http://journals.tums.ac.ir/upload_files/pdf/18477.pdf
_version_ 1818582774165012480
author Minoo Mohraz
Farhad Mehrkhani
Sara Jam
Seyed Ahmad SeyedAlinaghi
Duman Sabzvari
Fatemeh Fattahi
Hossain Jabbari
Mahboubeh Hajiabdolbaghi
author_facet Minoo Mohraz
Farhad Mehrkhani
Sara Jam
Seyed Ahmad SeyedAlinaghi
Duman Sabzvari
Fatemeh Fattahi
Hossain Jabbari
Mahboubeh Hajiabdolbaghi
author_sort Minoo Mohraz
collection DOAJ
description Toxoplasma gondii has arisen as an important opportunistic agent especially in the central nervous system and in advanced HIV disease can cause significant morbidity and mortality. This study was carried out to determine the seroprevalence of toxoplasmosis among HIV-positive patients in Iran. Blood samples were collected from 201 HIV-positive patients and anti-toxoplasma antibodies were detected by using conventional ELISA. An antibody titer of >3 IU/ml was considered positive. The majority of studied patients were male (male to female ratio: 5 to 1) with the mean age of 36 ± 1 yrs. The seroprevalence of toxoplasmosis in HIV-positive patients was 49.75%. The mean CD4 count in HIV patients with positive toxoplasma serology was 332.5 ± 22.4 cells/µl. Only 1% of the patients had IgM anti-toxoplasma antibodies and 10% of the patients had clinical toxoplasma encephalitis. The mean CD4 count in this group was 66.4 ± 15.5 cells/µl and there was a significant association between CD4 count and rate of toxoplasma encephalitis (P<0.001). Previous reports suggested that toxoplasma encephalitis could be prevented by appropriate chemoprophylaxis. In view of the relatively high prevalence of toxoplasma infection found among the HIV-infected patients in our study, we suggest that routine screening for toxoplasma should be undertaken for all HIV-infected patients in Iran.
first_indexed 2024-12-16T07:54:43Z
format Article
id doaj.art-7d8fd8a290744cd9a521d0a8401358bc
institution Directory Open Access Journal
issn 0044-6025
language English
last_indexed 2024-12-16T07:54:43Z
publishDate 2011-04-01
publisher Tehran University of Medical Sciences
record_format Article
series Acta Medica Iranica
spelling doaj.art-7d8fd8a290744cd9a521d0a8401358bc2022-12-21T22:38:45ZengTehran University of Medical SciencesActa Medica Iranica0044-60252011-04-01494213218Seroprevalence of Toxoplasmosis in HIV+/AIDS Patients in IranMinoo MohrazFarhad MehrkhaniSara JamSeyed Ahmad SeyedAlinaghiDuman SabzvariFatemeh FattahiHossain JabbariMahboubeh HajiabdolbaghiToxoplasma gondii has arisen as an important opportunistic agent especially in the central nervous system and in advanced HIV disease can cause significant morbidity and mortality. This study was carried out to determine the seroprevalence of toxoplasmosis among HIV-positive patients in Iran. Blood samples were collected from 201 HIV-positive patients and anti-toxoplasma antibodies were detected by using conventional ELISA. An antibody titer of >3 IU/ml was considered positive. The majority of studied patients were male (male to female ratio: 5 to 1) with the mean age of 36 ± 1 yrs. The seroprevalence of toxoplasmosis in HIV-positive patients was 49.75%. The mean CD4 count in HIV patients with positive toxoplasma serology was 332.5 ± 22.4 cells/µl. Only 1% of the patients had IgM anti-toxoplasma antibodies and 10% of the patients had clinical toxoplasma encephalitis. The mean CD4 count in this group was 66.4 ± 15.5 cells/µl and there was a significant association between CD4 count and rate of toxoplasma encephalitis (P<0.001). Previous reports suggested that toxoplasma encephalitis could be prevented by appropriate chemoprophylaxis. In view of the relatively high prevalence of toxoplasma infection found among the HIV-infected patients in our study, we suggest that routine screening for toxoplasma should be undertaken for all HIV-infected patients in Iran.http://journals.tums.ac.ir/upload_files/pdf/18477.pdfHIV/AIDSSeroprevalenceToxoplasma GondiiToxoplasmosis
spellingShingle Minoo Mohraz
Farhad Mehrkhani
Sara Jam
Seyed Ahmad SeyedAlinaghi
Duman Sabzvari
Fatemeh Fattahi
Hossain Jabbari
Mahboubeh Hajiabdolbaghi
Seroprevalence of Toxoplasmosis in HIV+/AIDS Patients in Iran
Acta Medica Iranica
HIV/AIDS
Seroprevalence
Toxoplasma Gondii
Toxoplasmosis
title Seroprevalence of Toxoplasmosis in HIV+/AIDS Patients in Iran
title_full Seroprevalence of Toxoplasmosis in HIV+/AIDS Patients in Iran
title_fullStr Seroprevalence of Toxoplasmosis in HIV+/AIDS Patients in Iran
title_full_unstemmed Seroprevalence of Toxoplasmosis in HIV+/AIDS Patients in Iran
title_short Seroprevalence of Toxoplasmosis in HIV+/AIDS Patients in Iran
title_sort seroprevalence of toxoplasmosis in hiv aids patients in iran
topic HIV/AIDS
Seroprevalence
Toxoplasma Gondii
Toxoplasmosis
url http://journals.tums.ac.ir/upload_files/pdf/18477.pdf
work_keys_str_mv AT minoomohraz seroprevalenceoftoxoplasmosisinhivaidspatientsiniran
AT farhadmehrkhani seroprevalenceoftoxoplasmosisinhivaidspatientsiniran
AT sarajam seroprevalenceoftoxoplasmosisinhivaidspatientsiniran
AT seyedahmadseyedalinaghi seroprevalenceoftoxoplasmosisinhivaidspatientsiniran
AT dumansabzvari seroprevalenceoftoxoplasmosisinhivaidspatientsiniran
AT fatemehfattahi seroprevalenceoftoxoplasmosisinhivaidspatientsiniran
AT hossainjabbari seroprevalenceoftoxoplasmosisinhivaidspatientsiniran
AT mahboubehhajiabdolbaghi seroprevalenceoftoxoplasmosisinhivaidspatientsiniran